Kemppainen R J, Sartin J L, Peterson M E
Department of Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, AL 36849.
Am J Vet Res. 1989 Nov;50(11):1914-7.
The effects of single IV administered doses of dexamethasone on response to the adrenocorticotropic hormone (ACTH) stimulation test (baseline plasma ACTH, pre-ACTH cortisol, and post-ACTH cortisol concentrations) performed 1, 2, and 3 days (experiment 1) or 3, 7, 10, and 14 days (experiment 2) after dexamethasone treatment were evaluated in healthy Beagles. In experiment 1, ACTH stimulation tests were carried out after administration of 0, 0.01, 0.1, 1, and 5 mg of dexamethasone/kg of body weight. Dosages greater than or equal to 0.1 mg of dexamethasone/kg decreased pre-ACTH plasma cortisol concentration on subsequent days, whereas dosages greater than or equal to 1 mg/kg also decreased plasma ACTH concentration. Treatment with 1 or 5 mg of dexamethasone/kg suppressed (P less than 0.05) post-ACTH plasma cortisol concentration (on day 3 after 1 mg of dexamethasone/kg; on days 1, 2, and 3 after 5 mg of dexamethasone/kg). In experiment 2, IV administration of 1 mg of dexamethasone/kg was associated only with low (P less than 0.05) post-ACTH plasma cortisol concentration in dogs on day 3. In experiment 2, pre-ACTH plasma cortisol and ACTH concentrations in dogs on days 3, 7, 10, and 14 and post-ACTH plasma cortisol concentration on days 7, 10, and 14 were not affected by dexamethasone administration. The results suggest that, in dogs, a single IV administered dosage of greater than or equal to 0.1 mg of dexamethasone/kg can alter the results of the ACTH stimulation test for at least 3 days. The suppressive effect of dexamethasone is dose dependent and is not apparent 7 days after treatment with 1 mg of dexamethasone/kg.(ABSTRACT TRUNCATED AT 250 WORDS)
在健康的比格犬中评估了静脉注射单剂量地塞米松对促肾上腺皮质激素(ACTH)刺激试验反应(基线血浆ACTH、ACTH前皮质醇和ACTH后皮质醇浓度)的影响,该试验在给予地塞米松治疗后的第1、2和3天(实验1)或第3、7、10和14天(实验2)进行。在实验1中,在给予0、0.01、0.1、1和5mg地塞米松/千克体重后进行ACTH刺激试验。剂量大于或等于0.1mg地塞米松/千克体重会在随后几天降低ACTH前血浆皮质醇浓度,而剂量大于或等于1mg/千克体重也会降低血浆ACTH浓度。用1或5mg地塞米松/千克体重治疗会抑制(P小于0.05)ACTH后血浆皮质醇浓度(1mg地塞米松/千克体重后第3天;5mg地塞米松/千克体重后第1、2和3天)。在实验2中,静脉注射1mg地塞米松/千克体重仅与第3天犬的ACTH后血浆皮质醇浓度低(P小于0.05)有关。在实验2中,第3、7、10和14天犬的ACTH前血浆皮质醇和ACTH浓度以及第7、10和14天的ACTH后血浆皮质醇浓度不受地塞米松给药的影响。结果表明,在犬中,静脉注射单剂量大于或等于0.1mg地塞米松/千克体重可改变ACTH刺激试验结果至少3天。地塞米松的抑制作用是剂量依赖性的,在用1mg地塞米松/千克体重治疗7天后不明显。(摘要截短至250字)